Cardiac ryanodine receptor and oxidative stress
心脏兰尼碱受体与氧化应激
基本信息
- 批准号:10632861
- 负责人:
- 金额:$ 5.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-09 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAreaArrhythmiaAutomobile DrivingAwardBiochemicalBiosensorCardiacCardiac MyocytesCardiovascular DiseasesCardiovascular PhysiologyClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCoupledCouplingCysteineDiseaseEnvironmentEnzyme InhibitionEnzymesFoundationsGenesGeneticGoalsHealthHeartHeart DiseasesHomeostasisHumanImpairmentInheritedLeadLinkMediatingMentorsModificationMolecularMolecular BiologyMolecular ChaperonesOhioOxidation-ReductionOxidative StressOxidoreductasePharmacologyPhaseProtein BiochemistryReactive Oxygen SpeciesRegulationResearchRodent ModelRoleRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumSourceStressSudden DeathSystemTechnologyTestingTherapeuticTrainingUnited StatesUniversitiesUp-RegulationViralcareerhuman modelinduced pluripotent stem cellinsightloss of functionnovelnovel therapeutic interventionprotein foldingsensor
项目摘要
PROJECT SUMMARY
Abnormal activity of the cardiac ryanodine receptor (RyR2) leads to increased and untimely release of Ca2+ from
the sarcoplasmic reticulum (SR), driving Ca2+-dependent arrhythmogenesis that can lead to sudden death in
many cardiac disorders. Oxidative modification of RyR2 by reactive oxygen species (ROS) has long been
established to enhance the sensitivity of the channels to Ca2+ within the SR (intraluminal Ca2+) in the failing heart.
However, both the intracellular source of ROS, as well as the specific redox-sensitive residues of RyR2 which
control intraluminal Ca2+ sensitivity, remain elusive. Our initial studies implicate the role of the SR oxidoreductase
system in this control, whereby molecular chaperones and enzymes that facilitate protein folding also modulate
activity of RyR2. We have identified intraluminal cysteines of RyR2 that elicit functional effects on the channel,
as well as an oxidoreductase chaperone that associates with the channel in a redox-dependent manner.
Moreover, we found upregulation of oxidoreductase enzyme in rodent models of cardiac disease, and observed
RyR2 activity stabilization with pharmacological inhibition of this enzyme. We therefore hypothesize that
dysregulation of the SR oxidoreductase system impairs luminal Ca2+ regulation of RyR2 via an ‘intraluminal SR
redox sensor’ and promotes arrhythmogenesis. We will test our hypothesis by 1) defining the molecular
components of the SR redox sensor that control luminal Ca2+ sensitivity of RyR2, and 2) determining the role of
dysregulated SR redox homeostasis in Ca2+-dependent arrhythmogenesis. To address these aims, we will
employ a multilevel experimental approach, investigating at the molecular, cellular, and whole heart level. We
propose to use heterologous systems, biochemical approaches and human induced pluripotent stem cell
cardiomyocyte (hiPSC-CM) technology to identify the RyR2 redox sensor. We also propose to study disease-
associated perturbations of the SR oxidoreductase system in rodent models of inherited and acquired Ca2+-
dependent arrhythmia, utilizing novel genetic biosensors, as well as adenoviral (AV) and adeno-associated viral
(AAV) gain- and loss- of function approaches. With renowned experts in cardiac EC coupling, protein
biochemistry and hiPSC-CM technology, The Ohio State University offers an exceptional training environment
for the mentored phase of the award to reach these goals. Furthermore, building on my strong background in
molecular biology, I will collaborate with an expert in CRISPR-mediated gene editing of hiPSC-CMs to study
these mechanisms in a relevant human model. The achievement of the proposed aims will uncover novel
regulatory mechanisms of RyR2 regulation, with potential to be therapeutically exploited. This proposal therefore
addresses a fruitful and unexplored research area, relevant to a spectrum of cardiovascular diseases, which will
lay strong foundations for an independent research career in cardiovascular physiology.
项目摘要
心脏ryanodine受体(RyR 2)的异常活性导致Ca 2+从心肌细胞中释放增加和过早释放。
肌浆网(SR),驱动Ca 2+依赖的促细胞生成,可导致猝死,
许多心脏疾病。RyR 2通过活性氧(ROS)的氧化修饰长期以来一直是研究的热点。
建立了增强通道对衰竭心脏中SR(管腔内Ca 2+)内Ca 2+的敏感性。
然而,细胞内ROS的来源,以及RyR 2的特异性氧化还原敏感残基,
控制管腔内Ca 2+敏感性,仍然难以捉摸。我们的初步研究暗示了SR氧化还原酶的作用
在这种控制中,分子伴侣和促进蛋白质折叠的酶也调节
RyR 2的活性。我们已经鉴定了RyR 2的管腔内半胱氨酸,其引起对通道的功能作用,
以及以氧化还原依赖性方式与通道结合的氧化还原酶伴侣。
此外,我们发现在啮齿动物心脏病模型中氧化还原酶上调,并观察到
RyR 2活性稳定与该酶的药理学抑制。因此,我们假设,
SR氧化还原酶系统的失调通过“管腔内SR”损害RyR 2的管腔Ca 2+调节
氧化还原传感器',并促进促细胞生成。我们将通过以下方式来检验我们的假设:1)定义分子
控制RyR 2的管腔Ca 2+敏感性的SR氧化还原传感器的组分,以及2)确定
钙离子依赖性肿瘤发生中SR氧化还原稳态失调。为了实现这些目标,我们将
采用多层次的实验方法,在分子,细胞和整个心脏水平上进行研究。我们
建议使用异源系统、生物化学方法和人诱导多能干细胞
心肌细胞(hiPSC-CM)技术来鉴定RyR 2氧化还原传感器。我们也建议研究疾病-
遗传性和获得性Ca 2 +-钙缺乏的啮齿动物模型中SR氧化还原酶系统的相关扰动
依赖性心律失常,利用新的遗传生物传感器,以及腺病毒(AV)和腺相关病毒
(AAV)功能获得和丧失的方法。与心脏EC偶联、蛋白质
俄亥俄州州立大学提供了一个特殊的培训环境,
为实现这些目标,该奖项的指导阶段。此外,基于我在
分子生物学,我将与CRISPR介导的hiPSC-CM基因编辑专家合作研究
这些机制在相关的人体模型中。所提出的目标的实现将揭示新的
RyR 2调节的调节机制,具有治疗开发的潜力。因此,这项建议
解决了一个富有成效的和未开发的研究领域,有关的一系列心血管疾病,这将
为心血管生理学的独立研究生涯奠定坚实的基础。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
To block or not to block: Targeting SK channels in diseased hearts.
阻断或不阻断:针对患病心脏中的 SK 通道。
- DOI:10.1016/j.yjmcc.2023.09.005
- 发表时间:2023
- 期刊:
- 影响因子:5
- 作者:Terentyev,Dmitry;Belevych,AndriyE;Choi,Bum-Rak;Hamilton,Shanna
- 通讯作者:Hamilton,Shanna
ER stress and calcium-dependent arrhythmias.
- DOI:10.3389/fphys.2022.1041940
- 发表时间:2022
- 期刊:
- 影响因子:4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shanna Hamilton其他文献
Shanna Hamilton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shanna Hamilton', 18)}}的其他基金
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 5.4万 - 项目类别:
Research Grant